ReviewAmerican journal of clinical dermatology2021

Cardiovascular Safety of Biologics Targeting Interleukin (IL)-12 and/or IL-23: What Does the Evidence Say?

Marianne de Brito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.